Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

Trial Details

NCT ID

NCT06395844

Phase

PHASE1 / PHASE2

Sponsor

Anhui Provincial Cancer Hospital

Status

RECRUITING

Cancer Type

Ovarian Cancer

Interventions

• METR-NK cell(Metabolic Remodeling Nature Killer Cells)

Locations (sample)

• Hefei, Anhui, China|31.86389,117.28083

Key Eligibility Criteria

• Age: 18-70 years old (≥18, ≤70);
• Open surgery, laparoscopic surgery, or coarse needle biopsy for histopathological confirmation of advanced (FIGO IIIC/IV stage) high-grade serous o…
• ECOG score: 0-1;
• Blood and tissue specimens before, during, and after treatment can be obtained, and subjects agree to submit blood and tissue specimens to the cent…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.